^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Neuvenge (lapuleucel-T)

    i
    Other names: HER-2/neu cancer vaccine, APC8024, DN24-02, BA 7072, APC 8024, DN2402
    Associations
    News
    Trials
    Company:
    Sanpower
    Drug class:
    HER2 inhibitor
    Related drugs:
    Associations
    News
    Trials